Assessment of P2Y12 Inhibition by Clopidogrel in Feline Platelets Using Flow Cytometry Quantification of Vasodilator-Stimulated Phosphoprotein Phosphorylation
The primary objective of this study was to evaluate a novel flow cytometry-based assay of quantifying platelet phosphorylation of vasodilator-stimulated phosphoprotein (P-VASP) in cats that received clopidogrel treatment. Eight healthy cats received 18.75 mg PO q24h of clopidogrel for 7 days. Prior...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-05-01
|
Series: | Frontiers in Veterinary Science |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fvets.2020.00267/full |
_version_ | 1818019470461894656 |
---|---|
author | Ronald H. L. Li Nghi Nguyen Tommaso Rosati Karl Jandrey |
author_facet | Ronald H. L. Li Nghi Nguyen Tommaso Rosati Karl Jandrey |
author_sort | Ronald H. L. Li |
collection | DOAJ |
description | The primary objective of this study was to evaluate a novel flow cytometry-based assay of quantifying platelet phosphorylation of vasodilator-stimulated phosphoprotein (P-VASP) in cats that received clopidogrel treatment. Eight healthy cats received 18.75 mg PO q24h of clopidogrel for 7 days. Prior to and after clopidogrel treatment, blood was collected for ADP-induced light transmission aggregometry (LTA) and P-VASP measurement by flow cytometry. Flow cytometry measurement of P-VASP levels was used to derive platelet reactivity index (PRI) before and after clopidogrel treatment. Based on P-VASP and LTA findings, platelet response to ADP was significantly attenuated after 7 days of clopidogrel treatment. By eliciting the competing platelet pathways of P2Y12 and cAMP using ADP and PGE1, respectively, ADP had no effect on P-VASP levels following clopidogrel treatment (p = 0.94). Clopidogrel also significantly decreased PRI from 28.84 ± 28.52% to 1.69 ± 12.39% (p = 0.0078). PRI on day 8 correlated moderately with the degree of slope inhibition on LTA (r = −0.4, p = 0.4). Flow cytometry analysis of P-VASP is effective at monitoring the inhibitory effects of clopidogrel on feline platelets. |
first_indexed | 2024-04-14T07:52:56Z |
format | Article |
id | doaj.art-7a9378b7ef6c42baba7b8867847352ac |
institution | Directory Open Access Journal |
issn | 2297-1769 |
language | English |
last_indexed | 2024-04-14T07:52:56Z |
publishDate | 2020-05-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Veterinary Science |
spelling | doaj.art-7a9378b7ef6c42baba7b8867847352ac2022-12-22T02:05:09ZengFrontiers Media S.A.Frontiers in Veterinary Science2297-17692020-05-01710.3389/fvets.2020.00267535223Assessment of P2Y12 Inhibition by Clopidogrel in Feline Platelets Using Flow Cytometry Quantification of Vasodilator-Stimulated Phosphoprotein PhosphorylationRonald H. L. Li0Nghi Nguyen1Tommaso Rosati2Karl Jandrey3Department of Veterinary Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Davis, Davis, CA, United StatesDepartment of Veterinary Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Davis, Davis, CA, United StatesWilliam R. Pritchard Veterinary Medical Teaching Hospital, University of California, Davis, Davis, CA, United StatesDepartment of Veterinary Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Davis, Davis, CA, United StatesThe primary objective of this study was to evaluate a novel flow cytometry-based assay of quantifying platelet phosphorylation of vasodilator-stimulated phosphoprotein (P-VASP) in cats that received clopidogrel treatment. Eight healthy cats received 18.75 mg PO q24h of clopidogrel for 7 days. Prior to and after clopidogrel treatment, blood was collected for ADP-induced light transmission aggregometry (LTA) and P-VASP measurement by flow cytometry. Flow cytometry measurement of P-VASP levels was used to derive platelet reactivity index (PRI) before and after clopidogrel treatment. Based on P-VASP and LTA findings, platelet response to ADP was significantly attenuated after 7 days of clopidogrel treatment. By eliciting the competing platelet pathways of P2Y12 and cAMP using ADP and PGE1, respectively, ADP had no effect on P-VASP levels following clopidogrel treatment (p = 0.94). Clopidogrel also significantly decreased PRI from 28.84 ± 28.52% to 1.69 ± 12.39% (p = 0.0078). PRI on day 8 correlated moderately with the degree of slope inhibition on LTA (r = −0.4, p = 0.4). Flow cytometry analysis of P-VASP is effective at monitoring the inhibitory effects of clopidogrel on feline platelets.https://www.frontiersin.org/article/10.3389/fvets.2020.00267/fullhypertrophic cardiomyopathyplatelet activation and signalinglight transmission aggregometryvasodilator stimulated phosphoproteincyclic AMP |
spellingShingle | Ronald H. L. Li Nghi Nguyen Tommaso Rosati Karl Jandrey Assessment of P2Y12 Inhibition by Clopidogrel in Feline Platelets Using Flow Cytometry Quantification of Vasodilator-Stimulated Phosphoprotein Phosphorylation Frontiers in Veterinary Science hypertrophic cardiomyopathy platelet activation and signaling light transmission aggregometry vasodilator stimulated phosphoprotein cyclic AMP |
title | Assessment of P2Y12 Inhibition by Clopidogrel in Feline Platelets Using Flow Cytometry Quantification of Vasodilator-Stimulated Phosphoprotein Phosphorylation |
title_full | Assessment of P2Y12 Inhibition by Clopidogrel in Feline Platelets Using Flow Cytometry Quantification of Vasodilator-Stimulated Phosphoprotein Phosphorylation |
title_fullStr | Assessment of P2Y12 Inhibition by Clopidogrel in Feline Platelets Using Flow Cytometry Quantification of Vasodilator-Stimulated Phosphoprotein Phosphorylation |
title_full_unstemmed | Assessment of P2Y12 Inhibition by Clopidogrel in Feline Platelets Using Flow Cytometry Quantification of Vasodilator-Stimulated Phosphoprotein Phosphorylation |
title_short | Assessment of P2Y12 Inhibition by Clopidogrel in Feline Platelets Using Flow Cytometry Quantification of Vasodilator-Stimulated Phosphoprotein Phosphorylation |
title_sort | assessment of p2y12 inhibition by clopidogrel in feline platelets using flow cytometry quantification of vasodilator stimulated phosphoprotein phosphorylation |
topic | hypertrophic cardiomyopathy platelet activation and signaling light transmission aggregometry vasodilator stimulated phosphoprotein cyclic AMP |
url | https://www.frontiersin.org/article/10.3389/fvets.2020.00267/full |
work_keys_str_mv | AT ronaldhlli assessmentofp2y12inhibitionbyclopidogrelinfelineplateletsusingflowcytometryquantificationofvasodilatorstimulatedphosphoproteinphosphorylation AT nghinguyen assessmentofp2y12inhibitionbyclopidogrelinfelineplateletsusingflowcytometryquantificationofvasodilatorstimulatedphosphoproteinphosphorylation AT tommasorosati assessmentofp2y12inhibitionbyclopidogrelinfelineplateletsusingflowcytometryquantificationofvasodilatorstimulatedphosphoproteinphosphorylation AT karljandrey assessmentofp2y12inhibitionbyclopidogrelinfelineplateletsusingflowcytometryquantificationofvasodilatorstimulatedphosphoproteinphosphorylation |